FIELD: medicine, dermatology. SUBSTANCE: invention proposes ceruletide that is a stimulating agent of gastric juice and a diagnostic agent ensuring to assay functional state of gall bladder and pancreas. Preparation administrated at doses 2.5-5 mg decreases itching, improves dream and causes softening and disappearance of psoriatic patches. In all patients suffering with psoriasis the preparation induces significant state improvement for 1-3 months after a single administration. A single use of ceruletide is sufficient for recovery of guttata psoriasis. In the case of the presence of "attendant" pitches it is necessary the repeated administration of preparation based on individual sensitivity of patients to ceruletide. EFFECT: enhanced effectiveness of an agent.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
OINTMENT FOR PSORIASIS TREATMENT | 1995 |
|
RU2091065C1 |
OINTMENT FOR TREATING PSORIASIS (VERSIONS) | 2018 |
|
RU2705162C1 |
METHOD OF TREATING PSORIASIS VULGARIS | 2010 |
|
RU2428159C1 |
METHOD OF TREATING PSORIASIS IN CHILDREN | 2006 |
|
RU2401123C2 |
METHOD FOR TREATING SKIN DISEASES | 2003 |
|
RU2245717C1 |
THERAPY OF PSORIASIS | 2008 |
|
RU2366432C1 |
METHOD FOR TREATING PSORIASIS | 2004 |
|
RU2278660C1 |
PSORIASIS TREATMENT METHOD | 1997 |
|
RU2142830C1 |
METHOD FOR TREATING PSORIASIS | 1998 |
|
RU2190406C2 |
Authors
Dates
1998-09-27—Published
1993-08-30—Filed